Variables | Diabetic patients (N = 30) | Controls (N = 30) | |
---|---|---|---|
Before lactoferrin | After lactoferrin | ||
PBM lysate | |||
TLR-4 (ng/mL) | 4.9 ± 1.0a | 3.76 ± 1.07b | 2.43 ± 0.69 |
NFκB-p65 (µg/mL) | 183.20 ± 49.19a | 98.68 ± 29.80b | 15.5 ± 2.87 |
Cyclin D-1 (ng/mL) | 8.13 ± 0.66a | 14.49 ± 1.2b | 21.43 ± 1.82 |
PBM nuclear extract | |||
PPAR-γ (ng/mL) | 2.78 ± 0.44a | 5.13 ± 0.56b | 7.79 ± 1.04 |
SIRT-1 (ng/mL) | 2.2 ± 0.6a | 2.6 ± 1.03b | 3.1 ± 2.04 |
NrF2/ARE binding activity | 0.06 ± 0.01a | 0.08 ± 0.01b | 0.12 ± 0.069 |